Shareholding disclosure

T. Rowe Price Associates, Inc

Declared position

2.96%

Threshold

Crossed upwards

Timeline

Published

11.01.2011

Transaction

30.12.2010

Voting rights breakdown

Voting rights acquired2.96%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAB1A00017

Beneficial owner

T. Rowe Price Associates, Inc

Declared address

T. ROWE PRICE ASSOCIATES, INC, MD 21202, BALTIMORE

T.Rowe Price Associate Inc ("TRPA") is the parent undertaking of T.Rowe Price International, INC ("TRPI"). TRPA and TRPI serve as investment adviser to clients that own 195,984 shares or 2.96% of Newron Pharmaceuticals Spa. As investment adviser, TRPA and TRPI make all adecisions regarding purchase and sale of Newron shares owned by their clients.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open